RXRX
Recursion Pharmaceuticals Inc.
$4.17
+$0.32(+8.31%)
45
Overall
60
Value
30
Tech
--
Quality
Market Cap
$2.54B
Volume
33.63M
52W Range
$3.79 - $12.36
Target Price
$6.30
EPS Estimates Overview
| Current Quarter | $-0.31 | Next Quarter | $NA |
| Current Year | $-1.6 | Next Year | $-1.22 |
| QoQ Growth | NaN% | YoY Growth | +23.8% |
| 3Y EPS CAGR | -4.3% | Target Price | $6.30 |
| Consensus | Buy | Upside | +51.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXRX | $4.17 | +8.3% | 33.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Recursion Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW